Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks

Completed

Phase N/A Results N/A

Summary of Purpose

The purpose of the study is to assess the occurrence of venous thromboembolism (blood clots), stroke, and heart attack in current users of ORTHO EVRA compared to current users of norgestimate-containing oral contraceptives with 35 mcg ethinyl estradiol with special attention to duration of use. The study uses data from the PharMetrics Patient-Centric Database and MarketScan database, which are US medical claims...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 July 2016.

1 Apr 2002 26 May 2006 1 Mar 2006 1 Mar 2006 1 Jul 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Case Control
  • Perspective: Retrospective
  • Sampling: Non-Probability Sample

Contacts

Not available